Dr. Reddy’s Laboratories has launched the Lansoprazole capsule in the over the counter (OTC) segment. Dr. Reddy’s launched the capsule this month after receiving the Abbreviated new Drug Application (ANDA) approval by the United States Food & Drug Administration (USFDA). The capsule is known to prevent acidity that can subsequently lead to heart burn. The capsule is available in 15 mg strength in 14, 28 and 42 count pack size.
The product is a bioequivalent version of the Novartis Prevacid 24 HR capsule that had received prescription to OTC switch approval by the FDA in Mar 2009 with 3 year exclusivity that ended recently in Mar 2012.